Potential Competitor To San Diego-Based Genomic Sequencing Giant Illumina Emerges From China
If the Chinese company's technology can do what executives say it can, then the competition it brings into the marketplace could drive down the already-plummeting cost of genome sequencing. Other industry news focuses on hospices, health care systems, and hospitals.
Can A Chinese Company's Powerful New Genome Sequencer Compete In The U.S.?
Nearly two years ago, the San Diego-based genomics giant Illumina reaffirmed its dominance of the DNA sequencing market when it announced a fast and powerful new machine, called the NovaSeq, that’s since been adopted in labs all over the world. (Robbins, 10/25)